The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Happy to see our Editorial in @JACCJournals out!
Proteome-wide MR is a powerful causal inference tool, but careful interpretation is essential. We discuss triangulation of evidence across ancestries, proteomic assays, and observational analyses.
https://authors.elsevier.com/a/1nWYi2d9GI5zkv
The
🧬 Une avancée majeure pour la médecine de précision au Québec
Le Dr Alan Spatz, directeur médical d’Optilab Montréal-CUSM, a fait partie d’un petit groupe d’experts invités par le ministère de la Santé et des Services sociaux (MSSS) à contribuer à l’élaboration de la toute
INCREDIBLE—thank you @CIHR_IRSC ! 🎉Congrats to all including our @QueensuSCRI's Drs. Mueller, Abraham, Parulekar, Ethier (CBG, CCE & CCT divisions), & Drs. Purzner, Talbot & Yang (Assoc members). BRAVO! @queenscce @QueensUHealth @QueensPathology @DbmsTweets @CDNCancerTrials
Les résultats du concours de subventions Projet du printemps 2026 sont enfin publiés!
Félicitations aux titulaires, et merci à nos pairs évaluateurs dévoués qui travaillent dans l’ombre pour orienter l’avenir de la recherche en santé.
https://cihr-irsc.gc.ca/f/54787.html?hsid=a51456a1-5fcc-49fe-9454-5262d7d60351&utm_medium=twitter&utm_source=irsc_cihr